Dayondon, Richard B.

HRN: 24-31-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
CEFUROXIME 1.5GM (VIAL)
01/01/2024
01/08/2024
1.5G
IV
Q8hrs
Lacerated Wound Secondary To VA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: